Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Business
Archived
•
October 29, 2026
•
2 views
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Source: CNBC Top | https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



